Wasteful Pre-Op Tests Can Be Reduced Safely
A study demonstrates safely reducing unnecessary pre-op tests can minimize waste and improve efficiency without compromising patient outcomes.
Read MorePosted by Chris Wolski | Feb 7, 2025 | Disease States |
A study demonstrates safely reducing unnecessary pre-op tests can minimize waste and improve efficiency without compromising patient outcomes.
Read MorePosted by Chris Wolski | Jan 31, 2025 | Sequencing Systems |
Baylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Sequencing Systems |
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Cardiovascular, Immunoassay |
Roche’s Tina-quant Lp(a) Gen.2 Molarity assay received FDA 510(k) clearance, supporting more precise cardiovascular risk assessment.
Read More